Hims Hers reverses plan for oral Wegovy, and its stock tumbled 20%
Feb 09, 2026
Hims Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk’s Wegovy oral weight-loss drug.
https://www.marketwatch.com/story/hims-hers-stock-poised-for-heavy-losses-after-quick-u-turn-on-plan-for-oral-wegovy-competitor-c859798e?mod=mw_rss_topstories
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service